Literature DB >> 30149398

[The Case Register for Coercive Measures According to the Law on Assistance for Persons with Mental Diseases of Baden-Wuerttemberg: Conception and First Evaluation].

Erich Flammer1, Tilman Steinert1.   

Abstract

BACKGROUND: In the federal state of Baden-Wuerttemberg, collecting data on coercive measures in psychiatric hospitals and supplying this data to a central register has been mandatory since 2015, so that statewide comprehensive data is available. This first full survey of the use of coercive measures in German psychiatric hospitals presents data of the year 2016 and allows comparisons with previous smaller samples.
METHODS: We analyzed the register data. The analysis is based on data provided by 32 facilities with 108,863 treated cases.
RESULTS: 10.7 % of admissions were involuntary at least at parts of their stay. 7,321 (6.7 %) cases were affected by any kind of freedom-restrictive measures (5.3 % mechanical restraint, 4.5 % seclusion). 674 cases (0.6 %) were affected by forced medication either as an emergency or after a judge's decision. The mean cumulative duration of freedom-restrictive measures was 45.9 hrs per admission. Time in seclusion or restraint accounted on 0.5 % of total time in hospital.
CONCLUSION: In comparison to previous studies in smaller samples, the use of coercive measures has considerably decreased in patients with delirium and dementia (ICD-10 F0). Coercive medication is rarely used. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30149398     DOI: 10.1055/a-0665-6728

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  9 in total

1.  [First conclusions from the register for coercive measures in Baden-Württemberg].

Authors:  T Steinert
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

2.  Measures to Avoid Coercion in Psychiatry and Their Efficacy.

Authors:  Sophie Hirsch; Tilman Steinert
Journal:  Dtsch Arztebl Int       Date:  2019-05-10       Impact factor: 5.594

3.  Implementation of Guidelines on Prevention of Coercion and Violence (PreVCo) in Psychiatry: Study Protocol of a Randomized Controlled Trial (RCT).

Authors:  Tilman Steinert; Andreas Bechdolf; Lieselotte Mahler; Rainer Muche; Johanna Baumgardt; Felix Bühling-Schindowski; Celline Cole; Marie Kampmann; Dorothea Sauter; Angelika Vandamme; Stefan Weinmann; Sophie Hirsch
Journal:  Front Psychiatry       Date:  2020-09-15       Impact factor: 4.157

4.  "Our Patients Are Different": Predictors of Seclusion and Restraint in 31 Psychiatric Hospitals.

Authors:  Erich Flammer; Sophie Hirsch; Nancy Thilo; Tilman Steinert
Journal:  Front Psychiatry       Date:  2022-04-26       Impact factor: 4.157

5.  Patients' perception of coercion with respect to antipsychotic treatment of psychotic disorders and its predictors.

Authors:  Sophie Hirsch; Nancy Thilo; Tilman Steinert; Erich Flammer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-04-27       Impact factor: 4.328

6.  Effect of the introduction of immediate judge's decisions in 2018 on the use of coercive measures in psychiatric hospitals in Germany: a population-based study.

Authors:  Erich Flammer; Sophie Hirsch; Tilman Steinert
Journal:  Lancet Reg Health Eur       Date:  2021-11-04

7.  Open Doors by Fair Means: a quasi-experimental controlled study on the effects of an open-door policy on acute psychiatric wards.

Authors:  Lisa K Schreiber; Florian G Metzger; Erich Flammer; Heike Rinke; Andreas J Fallgatter; Tilman Steinert
Journal:  BMC Health Serv Res       Date:  2022-07-22       Impact factor: 2.908

8.  Increase in coercive measures in psychiatric hospitals in Germany during the COVID-19 pandemic.

Authors:  Erich Flammer; Frank Eisele; Sophie Hirsch; Tilman Steinert
Journal:  PLoS One       Date:  2022-08-31       Impact factor: 3.752

9.  Freedom Restrictive Coercive Measures in Forensic Psychiatry.

Authors:  Erich Flammer; Udo Frank; Tilman Steinert
Journal:  Front Psychiatry       Date:  2020-03-05       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.